Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 218 de 371.

Grafa

Nanobiotix Nanoprimer enhances LNP-DNA delivery, reduces liver toxicity in preclinical trials

Nanobiotix (NASDAQ:NBTX), a late-clinical stage biotechnology company, announced the presentation of new preclinical data today at the 2026 Annual Meeting of the American Association for Cancer Research (AACR).

Leia mais: Nanobiotix Nanoprimer enhances LNP-DNA delivery, reduces liver toxicity in preclinical trials
Grafa

Medicus Pharma seeks FDA orphan drug status for novel microneedle skin cancer therapy

Medicus Pharma (NASDAQ:MDCX), a clinical-stage biopharmaceutical company, announced today that it has submitted an application for Orphan Drug Designation (ODD) to the U.S. Food and Drug Administration (FDA) for its flagship candidate, SkinJect (D-MNA).

Leia mais: Medicus Pharma seeks FDA orphan drug status for novel microneedle skin cancer therapy
Grafa

Gilead secures final regulatory clearance for $115-per-share Arcellx acquisition

Gilead Sciences (NASDAQ:GILD) announced today that it has cleared all necessary regulatory hurdles for its multi-billion dollar acquisition of Arcellx, marking the final steps toward integrating the biotech’s advanced cell therapy platform.

Leia mais: Gilead secures final regulatory clearance for $115-per-share Arcellx acquisition
Grafa
Industrials

SunOpta shareholders overwhelmingly approve $6.50 per share acquisition by Refresco

SunOpta (NASDAQ:STKL), a leading pioneer in sustainable, plant-based food and beverage supply chain solutions, announced today that its shareholders have overwhelmingly approved the company’s acquisition by an affiliate of Refresco Holding.

Leia mais: SunOpta shareholders overwhelmingly approve $6.50 per share acquisition by Refresco